Skip to main content
Top

Journal of Radiation Oncology

Issue 4/2019

Content (8 Articles)

Open Access Vestibular Schwannoma Review

Clinical outcomes and toxicity of proton radiotherapy for vestibular schwannomas: a systematic review

Kimberley S. Koetsier, Erik F. Hensen, Rudolf Wiggenraad, Irene M. Lips, Peter Paul G. van Benthem, Marco van Vulpen, Helen A. Shih

Laryngectomy Original Research

Complications and toxicity of re-irradiation following total laryngectomy for laryngeal cancer

Brent D. Waldron, Ariel B. Grobman, Mikhaylo Szczupak, Benjamin S. Farnia, Kaming Lo, Zoukaa Sargi, Michael Samuels

Glioblastoma : Original Research

Temporalis muscle width as a measure of sarcopenia correlates with overall survival in patients with newly diagnosed glioblastoma

Kristin Hsieh, Mark E. Hwang, Gabrielle Estevez-Inoa, Akshay V. Save, Anurag Saraf, Catherine S. Spina, Simon K. Cheng, Tony J. C. Wang, Cheng-Chia Wu

Lung Cancer Original Research

Delays in radiation therapy as a result of insurance peer-to-peer prior authorizations among lung cancer patients

Lucas Resende Salgado, William H. Smith, Anthony Nehlsen, Rendi Sheu, Audrey Saitta, Kavita Dharmarajan, Barry Rosenstein, Kenneth E. Rosenzweig

Brachytherapy Original Research

Outcome of surgery and radiotherapy for dermatofibrosarcoma protuberans: 5-year experience from two tertiary centers of eastern India

Anis Bandyopadhyay, Siddhartha Biswas, Harris Mahammad Sepai, Poulami Basu, Arnab Kumar Ghosh

Prostate Cancer Original Research

The value of prostate-specific antigen monitoring during salvage radiotherapy: a retrospective study and systematic review with meta-analysis

Riccardo Vigna-Taglianti, Alberto Boriano, Gunnar Lohm, Luca Gianello, Konrad Neumann, Elvio G. Russi

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine